Navigation Links
New therapy for HIV treatment
Date:7/29/2008

Millions of people world-wide who have contracted a highly resistant strain of the HIV virus could benefit from a new drug to treat the infection.

Research co-authored by the University of New South Wales' (UNSW) National Centre in HIV Epidemiology and Clinical Research (NCHECR) shows that the majority of patients who have not responded to traditional treatments have had good results from a new combination therapy.

The drug raltegravir is already available in Australia and was listed on the Pharmaceutical Benefits Scheme on July 1st, with clinical trials showing that it is safe, effective and with minimal side-effects when used with other anti-HIV medicines.

The study, which has been published in the New England Journal of Medicine, shows the raltegravir effectively lowers the amount of virus in the blood to undetectable levels in 62 percent of people taking it in combination with other anti-HIV medicines.

Only one in three people who received a placebo plus other anti-HIV medicines had the amount of virus in the blood reduced to similar levels.

"This is the first drug in a new class of antiretroviral drugs called integrase inhibitors," said UNSW Professor David Cooper AO, the Director of NCHECR .

"The drug has a different mechanism of action, is very potent, seems very safe and has helped patients who have a virus that is resistant to older drugs and classes," said Professor Cooper.

"It initially will be used in developed countries, but hopefully, it will be made available at cheaper prices for patients in developing countries who are facing the same problems," said Professor Cooper.

The results were based on analyses of viral load reductions and CD4 cell count increases. A high CD4 cell count is crucial for a healthy immune system.

Professor Cooper said the efficacy shown at 48 weeks of treatment was consistent with observations at 24 weeks, indicating that the drug in c
'/>"/>

Contact: Susi Hamilton
susi.hamilton@unsw.edu.au
61-293-851-583
University of New South Wales
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gentiva Safe Strides(R) Home Balance Therapy Program is Reducing Risk of Dangerous Falls and Relieving Pain for Thousands of Older Americans
2. Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
3. CSHL scientists correlate enzyme expression levels with chemotherapy drug response
4. D-cycloserine may improve behavioral therapy treatment for anxiety
5. Tx Xchange Launches Web-Based Solution for Physical Therapy and Rehabilitation Providers to Address Demands of Healthcare Consumerism
6. LSUHSC study finds high-dose HBO2 therapy extends survival window after cardiopulmonary arrest
7. Treating rare breast cancer with radiation therapy may lower recurrence rate
8. Medicare Modernization Act not associated with major changes in access to chemotherapy
9. Hormone Therapy Shows Little Benefit Against Prostate Cancer
10. Study points to cocktail therapy for Alzheimers
11. Global Med Technologies(R) Announces U.S. Release of Proven Tissue and Cellular Therapy Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... At the annual National League ... San Antonio, esteemed experts and thought leaders will ... in the way of successful organizational performance: resistance, ... faculty development opportunity is made possible through the ... to assist nurse educators to advance to leadership ...
(Date:12/21/2014)... In this report, the global powered ... product, and application. The market, by power source, ... By product, the market covers the handpieces; power ... market is further subdivided into drills, saws, reamers, ... shavers, wire/pin drivers, and others. Moreover, the power ...
(Date:12/21/2014)... Weddingshe.com, an outstanding online supplier of wedding dresses ... new selection of Cocktail Dresses for the winter 2014. ... newest fashion trends. , “We take pride ... . All of them are offered at greatly discounted ... every effort to offer a nice shopping experience for ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Khanna Vision ... a guest at the Aspen Helicopters holiday event for ... a Santa with sleigh, flown by an aspen helicopter ... invisible; only Santa with sleigh was visible.(please see accompanying ... and night. Dr.Khanna has helped many pilots with Pi ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 AngelWeddingDress.com’s new ... There is a total of 1,000 new designs in ... the coming spring 2015. , AngelWeddingDress.com promises ... female shoppers with wardrobe essentials while many fashion trends ... problems, the customer service team at AngelWeddingDress.com is ready ...
Breaking Medicine News(10 mins):Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2
... results across MDS, TORONTO, Sept. 6 /PRNewswire-FirstCall/ ... providing products and services to the global life ... For the quarter,MDS reported revenues of $321 million, ... from continuing operations of $0.07. Adjusted EBITDA,rose to ...
... product a proven treatment -, BELLEVILLE, ON, ... BNC), a research-based, technology-driven Canadian,biopharmaceutical company, today announced ... Australia in order to be able to respond ... continent,s equine influenza outbreak.,The outbreak began in August, ...
... N.Y., Sept. 6 /PRNewswire/, Who: Breast Cancer patients, survivors and ... (a breast cancer support center) on Thursday, September 6, What: ... ... wheels to encourage them to Keep ... to give cancer patients, survivors and caregivers a much needed ...
... Fairbank Farms, a national,ground beef producer, is ... Beef Patties. The ground beef patties, sold fresh,under ... consumers in New,England on Wednesday September 5, 2007 ... of caution, the product has been removed from ...
... Va., Sept. 5 AMERIGROUP,Corporation (NYSE: AGP ) ... Corporation have approved the sale of its assets,including TLC ... subject to regulatory approval by the State of Tennessee. ... of 2007. TLC Family Care Health Plan serves ...
... YORK, Sept. 5 Belfast Merger Co., a,wholly owned ... the expiration date for its cash tender offer for ... Inc. (Nasdaq: DADE ). The,tender offer has been ... September 26, 2007. The tender offer is being made ...
Cached Medicine News:Health News:MDS Reports Third Quarter 2007 Results 2Health News:MDS Reports Third Quarter 2007 Results 3Health News:MDS Reports Third Quarter 2007 Results 4Health News:MDS Reports Third Quarter 2007 Results 5Health News:MDS Reports Third Quarter 2007 Results 6Health News:MDS Reports Third Quarter 2007 Results 7Health News:MDS Reports Third Quarter 2007 Results 8Health News:MDS Reports Third Quarter 2007 Results 9Health News:MDS Reports Third Quarter 2007 Results 10Health News:MDS Reports Third Quarter 2007 Results 11Health News:MDS Reports Third Quarter 2007 Results 12Health News:MDS Reports Third Quarter 2007 Results 13Health News:MDS Reports Third Quarter 2007 Results 14Health News:MDS Reports Third Quarter 2007 Results 15Health News:MDS Reports Third Quarter 2007 Results 16Health News:MDS Reports Third Quarter 2007 Results 17Health News:MDS Reports Third Quarter 2007 Results 18Health News:MDS Reports Third Quarter 2007 Results 19Health News:MDS Reports Third Quarter 2007 Results 20Health News:MDS Reports Third Quarter 2007 Results 21Health News:MDS Reports Third Quarter 2007 Results 22Health News:MDS Reports Third Quarter 2007 Results 23Health News:MDS Reports Third Quarter 2007 Results 24Health News:MDS Reports Third Quarter 2007 Results 25Health News:MDS Reports Third Quarter 2007 Results 26Health News:MDS Reports Third Quarter 2007 Results 27Health News:MDS Reports Third Quarter 2007 Results 28Health News:MDS Reports Third Quarter 2007 Results 29Health News:MDS Reports Third Quarter 2007 Results 30Health News:MDS Reports Third Quarter 2007 Results 31Health News:MDS Reports Third Quarter 2007 Results 32Health News:MDS Reports Third Quarter 2007 Results 33Health News:Bioniche Responds to Australian Equine Influenza Outbreak 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 3Health News:New York City Cancer Patients, Survivors and Care Givers Encouraged to Keep Going(R) 2
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
(Date:12/17/2014)... Ariz. , Dec. 17, 2014  Beamz ... state-of-the-art interactive music products, today announced that it ... a leading manufacturer and supplier of innovative prosthetic, ... As part of the agreement, RSL Steeper ... bundled solution specifically configured for use within UK ...
(Date:12/17/2014)... Dec. 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... completion of enrollment in its first Phase 2a ... observations confirmed the 1-month findings that were reported ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
Icefire has ice crystals on the top of a cool blue iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Maumenee vitreous aspirating cannula, 18 gauge....
Medicine Products: